505 related articles for article (PubMed ID: 22269666)
41. Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study.
Leone G; Iacovelli P; Paro Vidolin A; Picardo M
J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):531-7. PubMed ID: 12941087
[TBL] [Abstract][Full Text] [Related]
42. A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo.
Zhang DM; Hong WS; Fu LF; Wei XD; Xu AE
Dermatol Surg; 2014 Apr; 40(4):420-6. PubMed ID: 24446755
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the 308-nm excimer laser with the 308-nm excimer lamp in the treatment of vitiligo--a randomized bilateral comparison study.
Shi Q; Li K; Fu J; Wang Y; Ma C; Li Q; Li C; Gao T
Photodermatol Photoimmunol Photomed; 2013 Feb; 29(1):27-33. PubMed ID: 23281694
[TBL] [Abstract][Full Text] [Related]
44. 308-nm excimer laser for the treatment of localized vitiligo.
Taneja A; Trehan M; Taylor CR
Int J Dermatol; 2003 Aug; 42(8):658-62. PubMed ID: 12890118
[TBL] [Abstract][Full Text] [Related]
45. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo.
Kullavanijaya P; Lim HW
Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875
[TBL] [Abstract][Full Text] [Related]
46. A review of monochromatic excimer light in vitiligo.
Park KK; Liao W; Murase JE
Br J Dermatol; 2012 Sep; 167(3):468-78. PubMed ID: 22524428
[TBL] [Abstract][Full Text] [Related]
47. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.
Nicolaidou E; Antoniou C; Stratigos AJ; Stefanaki C; Katsambas AD
J Am Acad Dermatol; 2007 Feb; 56(2):274-8. PubMed ID: 17224369
[TBL] [Abstract][Full Text] [Related]
48. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
49. No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo.
Ada S; Sahin S; Boztepe G; Karaduman A; Kölemen F
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):79-83. PubMed ID: 15752125
[TBL] [Abstract][Full Text] [Related]
50. Over-expression of tumor necrosis factor-α in vitiligo lesions after narrow-band UVB therapy: an immunohistochemical study.
Attwa E; Gamil H; Assaf M; Ghonemy S
Arch Dermatol Res; 2012 Dec; 304(10):823-30. PubMed ID: 22832941
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites.
Anbar TS; Westerhof W; Abdel-Rahman AT; El-Khayyat MA
Photodermatol Photoimmunol Photomed; 2006 Jun; 22(3):157-63. PubMed ID: 16719871
[TBL] [Abstract][Full Text] [Related]
52. Effect of narrow-band ultraviolet B on the serum of 25-hydroxyvitamin D in vitiligo patients.
Ibrahim H; El Taieb M; El Gamel Z; El Saied AR
J Cosmet Dermatol; 2018 Oct; 17(5):911-916. PubMed ID: 29524288
[TBL] [Abstract][Full Text] [Related]
53. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo.
Chimento SM; Newland M; Ricotti C; Nistico S; Romanelli P
J Drugs Dermatol; 2008 Mar; 7(3):258-63. PubMed ID: 18380207
[TBL] [Abstract][Full Text] [Related]
54. The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study.
Ibrahim ZA; El-Ashmawy AA; El-Tatawy RA; Sallam FA
J Cosmet Dermatol; 2016 Jun; 15(2):108-16. PubMed ID: 26695436
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy.
Hallaji Z; Ghiasi M; Eisazadeh A; Damavandi MR
Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):115-9. PubMed ID: 22548391
[TBL] [Abstract][Full Text] [Related]
56. A retrospective study of narrowband-UVB phototherapy for treatment of vitiligo in Malaysian patients.
Adauwiyah J; Suraiya HH
Med J Malaysia; 2010 Dec; 65(4):297-9. PubMed ID: 21901949
[TBL] [Abstract][Full Text] [Related]
57. Comparison between 308-nm excimer light alone versus 308-nm excimer light and platelet-rich plasma in the treatment for localized vitiligo.
Elsaadany AE; El-Khalawany M; Elshahid AR; Seddeik Abdel-Hameed AK
J Cosmet Dermatol; 2022 Jul; 21(7):2826-2831. PubMed ID: 34719101
[TBL] [Abstract][Full Text] [Related]
58. Treatment of localized vitiligo with targeted broadband UVB phototherapy: a pilot study.
Asawanonda P; Charoenlap M; Korkij W
Photodermatol Photoimmunol Photomed; 2006 Jun; 22(3):133-6. PubMed ID: 16719866
[TBL] [Abstract][Full Text] [Related]
59. Narrowband UVB therapy for vitiligo: does the repigmentation last?
Sitek JC; Loeb M; Ronnevig JR
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):891-6. PubMed ID: 17658996
[TBL] [Abstract][Full Text] [Related]
60. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
